NORTH AMERICA PULMONARY DRUG DELIVERY MARKET FORECAST 2019-2028

  • You are here:
  • Home
  • Reports
  • NORTH AMERICA PULMONARY DRUG DELIVERY MARKET FORECAST 2019-2028

NORTH AMERICA PULMONARY DRUG DELIVERY MARKET FORECAST 2019-2028

The North America pulmonary drug delivery market is registered to grow with a CAGR of 4.40%, during the forecast years of 2019 to 2028. The surging prevalence of chronic obstructive pulmonary disease (COPD) and asthma, and an increase in the geriatric population is projected to drive the region’s market growth. The United States and Canada are assessed for determining North America pulmonary drug delivery market growth.

NORTH AMERICA PULMONARY DRUG DELIVERY MARKET FORECAST 2019-2028

North America Pulmonary Drug Delivery Market by Application (Asthma, Chronic Obstructive Pulmonary Disease, Allergic Rhinitis, Cystic Fibrosis, Other Applications) by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-commerce) by End-user (Hospitals & Clinics, Homecare) by Product (Metered Dose Inhalers, Dry Powder Inhalers, Nebulizer (Pneumatic Nebulizer (Breath Actuated Pneumatic Nebulizer, Vented Pneumatic Nebulizer),  Mesh Nebulizer (Vibrating Mesh Nebulizer, Static Mesh Nebulizer), Ultrasonic Nebulizer), Accessories) and by Geography.

Request free sample

The North America pulmonary drug delivery market is registered to grow with a CAGR of 4.40%, during the forecast years of 2019 to 2028. The surging prevalence of chronic obstructive pulmonary disease (COPD) and asthma, and an increase in the geriatric population is projected to drive the region’s market growth.

north-america-pulmonary-drug-delivery-market

To know more about this report, request a free sample copy

The United States and Canada are assessed for determining North America pulmonary drug delivery market growth. The United States is the largest market for pulmonary drug delivery systems, owing to the high prevalence of chronic obstructive pulmonary disorder (COPD) and asthma, in the region. Likewise, according to the National Institutes of Health (NIH), nearly 12 million adults have been diagnosed with COPD in the country, with 120,000 fatalities every year. Thus, the increasing incidence of respiratory diseases is a predominant factor predicted to drive market growth.

Conversely, government initiatives like the National Asthma Control Program (NACP) offer financial assistance for educating patients with asthma and increasing the condition’s cognizance. These directives are also projected to contribute towards encouraging the use of pulmonary drug delivery for treating COPD and asthma. Additionally, the demand and supply within the pulmonary drug delivery market are further fuelled by the surging number of people suffering from COPD emphysema and cystic fibrosis, among other respiratory conditions, incorporated with the increasing awareness regarding the use of technically advanced devices.

3M Company, headquartered in the United States, is a diversified technology enterprise, functional in several industries such as safety and graphics, industrial, health care, consumer, and electronics, and energy. In August 2020, 3M and Mitsubishi Paper Mills completed the patent license agreement for 3M’s Metal Mesh Technology.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • PARENT MARKET ANALYSIS: DRUG DELIVERY MARKET
    • DEVELOPMENT OF DRUG DELIVERY SYSTEM
    • MARKET DEFINITION
    •    KEY DRIVERS
      • GROWING PREVALENCE OF RESPIRATORY DISEASE
      • ADVANCEMENTS IN TECHNOLOGY
      • RISING GERIATRIC POPULATION
    •    KEY RESTRAINTS
      • STRINGENT REGULATION AND PATENT EXPIRY
      • INCREASING DRUG RECALLS AND DRUG FAILURES
      • SIDE EFFECTS AND RISK ASSOCIATED WITH THE DRUGS
  1. KEY ANALYTICS
    •    PORTER’S FIVE FORCE ANALYSIS
      • THREAT OF NEW ENTRY
      • THREAT OF SUBSTITUTION
      • BUYER’S POWER
      • SUPPLIER’S POWER
      • COMPETITIVE RIVALRY
    • REGULATORY FRAMEWORK
    • IMPACT OF COVID-19 ON PULMONARY DRUG DELIVERY MARKET
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • KEY INVESTMENT INSIGHTS
  2. MARKET BY APPLICATION
    • ASTHMA
    • CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    • ALLERGIC RHINITIS
    • CYSTIC FIBROSIS
    • OTHER APPLICATIONS
  3. MARKET BY DISTRIBUTION CHANNEL
    • HOSPITAL PHARMACIES
    • RETAIL PHARMACIES
    • E-COMMERCE
  4. MARKET BY END-USER
    • HOSPITALS & CLINICS
    • HOMECARE
  5. MARKET BY PRODUCT
    • METERED DOSE INHALERS
    • DRY POWDER INHALERS
    •    NEBULIZER
      • PNEUMATIC NEBULIZER
      • MESH NEBULIZER
      • ULTRASONIC NEBULIZER
    • ACCESSORIES
  6. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. COMPANY PROFILES
    • 3M COMPANY
    • ACTELION PHARMACEUTICALS LTD
    • AEROGEN
    • AGILENT TECHNOLOGIES INC
    • ASTRAZENECA PLC
    • BOEHRINGER INGELHEIM GMBH
    • CLEMENT CLARKE INTERNATIONAL
    • GF HEALTH PRODUCTS INC
    • GLAXOSMITHKLINE PLC
    • KONINKLIJKE PHILIPS NV
    • MERCK & CO INC
    • NOVARTIS AG
    • TEVA PHARMACEUTICAL INDUSTRIES LIMITED
    • VECTURA GROUP PLC

TABLE LIST

TABLE 1: MARKET SNAPSHOT – PULMONARY DRUG DELIVERY

TABLE 2: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 3: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 4: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 5: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 6: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 7: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 8: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 9: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 10: NORTH AMERICA NEBULIZER MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 11: NORTH AMERICA NEBULIZER MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 12: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 13: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

FIGURE 2: OPPORTUNITY MATRIX

FIGURE 3: VENDOR LANDSCAPE

FIGURE 4: KEY INVESTMENT INSIGHTS

FIGURE 5: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY APPLICATION, IN 2019

FIGURE 6: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY ASTHMA, 2019-2028 (IN $ MILLION)

FIGURE 7: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019-2028 (IN $ MILLION)

FIGURE 8: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY ALLERGIC RHINITIS, 2019-2028 (IN $ MILLION)

FIGURE 9: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY CYSTIC FIBROSIS, 2019-2028 (IN $ MILLION)

FIGURE 10: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ MILLION)

FIGURE 11: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, IN 2019

FIGURE 12: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY HOSPITAL PHARMACIES, 2019-2028 (IN $ MILLION)

FIGURE 13: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY RETAIL PHARMACIES, 2019-2028 (IN $ MILLION)

FIGURE 14: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY E-COMMERCE, 2019-2028 (IN $ MILLION)

FIGURE 15: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY END-USER, IN 2019

FIGURE 16: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY HOSPITALS & CLINICS, 2019-2028 (IN $ MILLION)

FIGURE 17: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY HOMECARE, 2019-2028 (IN $ MILLION)

FIGURE 18: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY PRODUCT, IN 2019

FIGURE 19: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY METERED DOSE INHALERS, 2019-2028 (IN $ MILLION)

FIGURE 20: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY DRY POWDER INHALERS, 2019-2028 (IN $ MILLION)

FIGURE 21: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY NEBULIZER, 2019-2028 (IN $ MILLION)

FIGURE 22: NORTH AMERICA NEBULIZER MARKET, BY PNEUMATIC NEBULIZER, 2019-2028 (IN $ MILLION)

FIGURE 23: NORTH AMERICA NEBULIZER MARKET, BY MESH NEBULIZER, 2019-2028 (IN $ MILLION)

FIGURE 24: NORTH AMERICA NEBULIZER MARKET, BY ULTRASONIC NEBULIZER, 2019-2028 (IN $ MILLION)

FIGURE 25: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY ACCESSORIES, 2019-2028 (IN $ MILLION)

FIGURE 26: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 27: THE UNITED STATES PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)

FIGURE 28: CANADA PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. MARKET BY APPLICATION
    • ASTHMA
    • CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    • ALLERGIC RHINITIS
    • CYSTIC FIBROSIS
    • OTHER APPLICATIONS
  2. MARKET BY DISTRIBUTION CHANNEL
    • HOSPITAL PHARMACIES
    • RETAIL PHARMACIES
    • E-COMMERCE
  3. MARKET BY END-USER
    • HOSPITALS & CLINICS
    • HOMECARE
  4. MARKET BY PRODUCT
    • METERED DOSE INHALERS
    • DRY POWDER INHALERS
    •    NEBULIZER
      • PNEUMATIC NEBULIZER
      • MESH NEBULIZER
      • ULTRASONIC NEBULIZER
    • ACCESSORIES

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now